Publicacións en colaboración con investigadores/as de Pfizer (United States) (3)

2021

  1. Cost and burden of poor anticoagulation control with vitamin K antagonists in patients with nonvalvular atrial fibrillation in Spain

    Revista Espanola de Cardiologia, Vol. 74, Núm. 9, pp. 773-780

2019

  1. ICUSI questionnaire validation. Quality of anticoagulation in patients with atrial fibrillation treated with vitamin K antagonists

    REC: CardioClinics, Vol. 54, Núm. 3, pp. 165-172

2007

  1. A 6-month prospective, observational, naturalistic, uncontrolled study to evaluate the effectiveness and tolerability of oral ziprasidone in patients with schizophrenia

    European Neuropsychopharmacology, Vol. 17, Núm. 6-7, pp. 456-463